• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OCC

ORTHOCELL LIMITED

3.20% ! $1.29
Market Cap $312.1M  !

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OCC 13:21 34 10K
13:21 Last post  humpday Comments Created with Sketch.  34  Views Created with Sketch.  10K 
OCC 24/04/25 29 9.7K
24/04/25 Last post  jackphil Comments Created with Sketch.  29  Views Created with Sketch.  9.7K 
OCC
Media thread
15 16 17
24/04/25 991 378K
24/04/25 Last post  dp4 Comments Created with Sketch.  991  Views Created with Sketch.  378K 
OCC
OCC Trading
37 38 39
23/04/25 2.3K 804K
23/04/25 Last post  Ollie3039 Comments Created with Sketch.  2.3K  Views Created with Sketch.  804K 
OCC
Orthocell sees US Remplir sales on immediate horizon as distro deal locked in
23/04/25 0 232
23/04/25 Last post  ASX Insights Comments Created with Sketch.  0  Views Created with Sketch.  232 
OCC
2024/2025 Catalysts
2 3 4
23/04/25 220 82K
23/04/25 Last post  flummoxedtrader Comments Created with Sketch.  220  Views Created with Sketch.  82K 
OCC
OCC chart
40 41 42
22/04/25 2.5K 1.2M
22/04/25 Last post  sabine Comments Created with Sketch.  2.5K  Views Created with Sketch.  1.2M 
OCC 18/04/25 135 44K
18/04/25 Last post  rae915 Comments Created with Sketch.  135  Views Created with Sketch.  44K 

See All Discussions arrow Created with Sketch.

Timeline

First US Distributors Signed for Remplirs US$1.6B market
23 Apr 09:41
 
Quarterly Activity Report & Appendix 4C
14 Apr 08:52
 
Remplir Regulatory Application Submitted for Hong Kong
10 Apr 09:00
 
Regulatory Approval for Striate in US$65M Brazilian Market
09 Apr 09:19
 
Orthocell Webinar Details - Remplir US FDA 510(k) Clearance
04 Apr 09:23
 
Investor Presentation - US FDA 510(k) Clearance for Remplir
04 Apr 09:23
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.29
Change
0.040(3.20%)
Mkt cap ! $312.1M
Open High Low Value Volume
$1.28 $1.34 $1.26 $2.080M 1.597M

Buyers (Bids)

No. Vol. Price($)
1 14217 $1.29
 

Sellers (Offers)

Price($) Vol. No.
$1.31 30329 2
View Market Depth
Last trade - 16.10pm 25/04/2025 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.